Vaccinex Price on December 19, 2024
VCNXDelisted Stock | USD 1.09 0.01 0.91% |
If you're considering investing in Vaccinex Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vaccinex stands at 1.09, as last reported on the 31st of December, with the highest price reaching 1.20 and the lowest price hitting 1.07 during the day. Vaccinex owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0457, which indicates the firm had a -0.0457% return per unit of risk over the last 3 months. Vaccinex exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vaccinex's Variance of 149.34, risk adjusted performance of (0.04), and Coefficient Of Variation of (1,705) to confirm the risk estimate we provide.
Vaccinex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Vaccinex |
Sharpe Ratio = -0.0457
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | VCNX |
Estimated Market Risk
12.56 actual daily | 96 96% of assets are less volatile |
Expected Return
-0.57 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Vaccinex is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vaccinex by adding Vaccinex to a well-diversified portfolio.
Related Headline
Salarius Pharmaceuticals Headline on 19th of December 2024
Zomedica Appoints Scott A. Jordan Executive Vice President, ... by finance.yahoo.com
Seasoned executive brings a broad skill set to Zomedicas leadership team ANN ARBOR, MI ACCESSWIRE December 19, 2024 Zomedica Corp. , a veterinary health company offering point-of-care diagnostics ...
Vaccinex Valuation on December 19, 2024
It is possible to determine the worth of Vaccinex on a given historical date. On December 19, 2024 Vaccinex was worth 1.0 at the beginning of the trading date compared to the closed value of 1.01. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vaccinex stock. Still, in general, we apply an absolute valuation method to find Vaccinex's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vaccinex where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vaccinex's related companies.
Open | High | Low | Close | Volume | |
1.40 | 1.41 | 1.05 | 1.06 | 94,871 | |
12/19/2024 | 1.00 | 1.14 | 0.76 | 1.01 | 50,880 |
1.09 | 1.36 | 1.00 | 1.21 | 28,741 |
Backtest Vaccinex | | | Vaccinex History | | | Vaccinex Valuation | Previous | Next |
Vaccinex Trading Date Momentum on December 19, 2024
On December 20 2024 Vaccinex was traded for 1.21 at the closing time. The top price for the day was 1.36 and the lowest listed price was 1.00 . The trading volume for the day was 28.7 K. The trading history from December 20, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 19.80% . The trading price change against the current closing price is 8.91% . |
Vaccinex Fundamentals Correlations and Trends
By evaluating Vaccinex's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vaccinex's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vaccinex financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Vaccinex Stock history
Vaccinex investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vaccinex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vaccinex will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vaccinex stock prices may prove useful in developing a viable investing in Vaccinex
Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through the inhibition of semaphorin 4D . Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York. Vaccinex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.
Vaccinex Stock Technical Analysis
Vaccinex technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Vaccinex Period Price Range
Low | December 31, 2024
| High |
0.00 | 0.00 |
Vaccinex cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Vaccinex December 31, 2024 Market Strength
Market strength indicators help investors to evaluate how Vaccinex stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vaccinex shares will generate the highest return on investment. By undertsting and applying Vaccinex stock market strength indicators, traders can identify Vaccinex entry and exit signals to maximize returns
Vaccinex Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Vaccinex's price direction in advance. Along with the technical and fundamental analysis of Vaccinex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vaccinex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.73) | |||
Total Risk Alpha | (0.76) | |||
Treynor Ratio | (0.28) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaccinex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Consideration for investing in Vaccinex Stock
If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |